tiprankstipranks
Trending News
More News >
PDS Biotechnology Corporation (PDSB)
NASDAQ:PDSB
US Market

PDS Biotechnology (PDSB) Income Statement

Compare
715 Followers

PDS Biotechnology Income Statement

Last quarter (Q3 2024), PDS Biotechnology's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, PDS Biotechnology's net income was $-10.73M. See PDS Biotechnology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -57.33K$ -49.08K$ -246.39K$ -176.29K
Operating Expenses
$ 36.32B$ 43.05M$ 41.67M$ 21.44M$ 14.90M
Depreciation and Amortization
$ 0.00$ 57.33K$ 49.08K$ 246.39K$ 176.29K
EBITDA
$ -36.32B$ -40.08M$ -41.62M$ -21.19M$ -14.67M
Operating Income
$ -36.32B$ -43.05M$ -41.67M$ -21.44M$ -14.90M
Other Income/Expenses
$ -2.16B$ -1.30M$ -381.34K$ 4.35K$ 55.01K
Pretax Income
$ -38.48B$ -44.35M$ -42.05M$ -21.43M$ -14.85M
Net Income
$ -39.35B$ -42.94M$ -40.85M$ -16.92M$ -14.85M
Per Share Metrics
Basic EPS
$ -1.08K$ -1.39$ -1.43$ -0.66$ -0.89
Diluted EPS
$ -1.08K$ -1.39$ -1.43$ -0.66$ -0.89
Weighted Average Shares Outstanding
36.45M 30.95M 28.60M 25.60M 16.75M
Weighted Average Shares Outstanding (Diluted)
36.45M 30.95M 28.60M 25.60M 16.75M
Currency in USD

PDS Biotechnology Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis